Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto J Montero

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|August 7, 2015
Guidelines are essential to improving clinical outcomes in breast cancer patientsAlberto J Montero
The Oncologist|December 6, 2013
On being a dollAlberto J Montero
The New England Journal of Medicine|January 27, 2012
Fighting fire with fire: rekindling the bevacizumab debateAlberto J Montero, Charles Vogel
Drugs|August 5, 2011
Cellular redox pathways as a therapeutic target in the treatment of cancerAlberto J Montero, Jacek Jassem
Cleveland Clinic Journal of Medicine|July 12, 2016
Detecting cancer: Pearls for the primary care physicianSimon B Zeichner, Alberto J Montero
Biomarkers in Cancer|November 20, 2013
Molecular profiling for breast cancer: a comprehensive reviewMuaiad Kittaneh, Alberto J Montero, Stefan Glück
Frontiers in Cardiovascular Medicine|August 26, 2022
Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatmentAvirup Guha, Nickolas Stabellini, Alberto J Montero
Cancer Treatment Reviews|May 10, 2011
Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancerJavier Cortes, Alberto J Montero, Stefan Glück
Pharmacoeconomics|December 17, 2013
Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorialVakaramoko Diaby, Georges Adunlin, Alberto J Montero
Therapeutics and Clinical Risk Management|April 2, 2009
Gemcitabine and taxanes in metastatic breast cancer: a systematic reviewVinay Gudena, Alberto J Montero, Stefan Glück
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|August 7, 2015
Guidelines are essential to improving clinical outcomes in breast cancer patientsAlberto J Montero
The Oncologist|December 6, 2013
On being a dollAlberto J Montero
The New England Journal of Medicine|January 27, 2012
Fighting fire with fire: rekindling the bevacizumab debateAlberto J Montero, Charles Vogel
Drugs|August 5, 2011
Cellular redox pathways as a therapeutic target in the treatment of cancerAlberto J Montero, Jacek Jassem
Cleveland Clinic Journal of Medicine|July 12, 2016
Detecting cancer: Pearls for the primary care physicianSimon B Zeichner, Alberto J Montero
Biomarkers in Cancer|November 20, 2013
Molecular profiling for breast cancer: a comprehensive reviewMuaiad Kittaneh, Alberto J Montero, Stefan Glück
Frontiers in Cardiovascular Medicine|August 26, 2022
Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatmentAvirup Guha, Nickolas Stabellini, Alberto J Montero
Cancer Treatment Reviews|May 10, 2011
Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancerJavier Cortes, Alberto J Montero, Stefan Glück
Pharmacoeconomics|December 17, 2013
Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorialVakaramoko Diaby, Georges Adunlin, Alberto J Montero
Therapeutics and Clinical Risk Management|April 2, 2009
Gemcitabine and taxanes in metastatic breast cancer: a systematic reviewVinay Gudena, Alberto J Montero, Stefan Glück
Pageof 14